Sorafenib plus tislelizumab as maintenance therapy for patients with advanced hepatocellular carcinoma treated with transarterial chemoembolization: A phase II study.

被引：0
|
作者：
Cai, Mingyue [1 ]
Hong, Xiaoyang [1 ]
Huang, Wensou [1 ]
Guo, Yongjian [1 ]
Shi, Wenbo [1 ]
Liang, Licong [1 ]
Zhou, Jingwen [1 ]
Lin, Liteng [1 ]
Chen, Ye [1 ]
Zhu, Kangshun [1 ]
机构：
[1] Guangzhou Med Univ, Affiliated Hosp 2, Guangzhou, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
574
引用
收藏
页码：574 / 574
页数：1
相关论文
共 50 条
  • [1] Sintilimab plus bevacizumab as maintenance therapy for patients with unresectable hepatocellular carcinoma treated with transarterial chemoembolization: A phase Ib study.
    Cai, Mingyue
    Liang, Wei
    Huang, Wensou
    Guo, Yongjian
    Liang, Licong
    Zhou, Jingwen
    Lin, Liteng
    Deng, Haihui
    Zhu, Kangshun
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16) : E16165 - E16165
  • [2] Phase II study of concurrent transarterial chemoembolization and sorafenib in patients with unresectable hepatocellular carcinoma
    Park, Joong-Won
    Koh, Young Hwan
    Kim, Hyun Beom
    Kim, Hwi Young
    An, Sangbu
    Choi, Joon-Il
    Woo, Sang Myung
    Nam, Byung-Ho
    JOURNAL OF HEPATOLOGY, 2012, 56 (06) : 1336 - 1342
  • [3] Early prediction of survival in hepatocellular carcinoma patients treated with transarterial chemoembolization plus sorafenib
    Xiao-Chun Meng
    Bing-Hui Chen
    Jing-Jun Huang
    Wen-Sou Huang
    Ming-Yue Cai
    Jing-Wen Zhou
    Yong-Jian Guo
    Kang-Shun Zhu
    World Journal of Gastroenterology, 2018, (04) : 484 - 493
  • [4] Early prediction of survival in hepatocellular carcinoma patients treated with transarterial chemoembolization plus sorafenib
    Meng, Xiao-Chun
    Chen, Bing-Hui
    Huang, Jing-Jun
    Huang, Wen-Sou
    Cai, Ming-Yue
    Zhou, Jing-Wen
    Guo, Yong-Jian
    Zhu, Kang-Shun
    WORLD JOURNAL OF GASTROENTEROLOGY, 2018, 24 (04) : 484 - 493
  • [5] Sorafenib plus transarterial chemoembolization for unresectable hepatocellular carcinoma
    Tsilimigras, Diamantis I.
    Pawlik, Timothy M.
    ANNALS OF TRANSLATIONAL MEDICINE, 2020, 8 (23)
  • [6] Lenvatinib, sintilimab plus transarterial chemoembolization for advanced stage hepatocellular carcinoma: A phase II study
    Cai, Mingyue
    Huang, Wensou
    Liang, Wei
    Guo, Yongjian
    Liang, Licong
    Lin, Liteng
    Xie, Lulu
    Zhou, Jingwen
    Chen, Ye
    Cao, Bihui
    Wu, Jingqiang
    Zhu, Kangshun
    LIVER INTERNATIONAL, 2024, 44 (04) : 920 - 930
  • [7] The Efficacy of Transarterial Chemoembolization plus Apatinib or Sorafenib in the Treatment of Advanced Hepatocellular Carcinoma
    Chen, Lei
    Sun, Tao
    Wu, Linxia
    Zhang, Weihua
    Ren, Yanqiao
    Xiang, Dongqiao
    Liang, Bin
    Zheng, Chuansheng
    JOURNAL OF ONCOLOGY, 2021, 2021
  • [8] Transarterial chemoembolization combined with sorafenib for advanced hepatocellular carcinoma
    Shao, Wenbo
    Zhang, Fengjuan
    Cong, Ning
    Li, Jinpeng
    Song, Jinlong
    ONCOLOGY LETTERS, 2014, 8 (05) : 2263 - 2266
  • [9] Role of transarterial chemoembolization in relation with sorafenib for patients with advanced hepatocellular carcinoma
    Ha, Yeonjung
    Lee, Danbi
    Shim, Ju Hyun
    Lim, Young-Suk
    Lee, Han Chu
    Chung, Young-Hwa
    Lee, Yung Sang
    Park, Sook Ryun
    Ryu, Min-Hee
    Ryoo, Baek-Yeol
    Kang, Yoon-Koo
    Kim, Kang Mo
    ONCOTARGET, 2016, 7 (45) : 74303 - 74313
  • [10] The Impact of Combined Transarterial Chemoembolization on the Overall Survival of Patients with Advanced Hepatocellular Carcinoma Treated with Sorafenib
    Chen, Lufeng
    Su, Hongying
    Shao, Haibo
    Xu, Ke
    Liang, Songnian
    Liu, Ling
    HEPATO-GASTROENTEROLOGY, 2014, 61 (131) : 802 - 808
12345